Literature DB >> 30561613

Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC).

Antonio Pelliccia1, Erik Ekker Solberg2, Michael Papadakis3, Paolo Emilio Adami1,4, Alessandro Biffi1, Stefano Caselli5, Andrè La Gerche6, Josef Niebauer7, Axel Pressler8,9, Christian M Schmied10, Luis Serratosa11,12, Martin Halle8,9, Frank Van Buuren13, Mats Borjesson14,15, Francois Carrè16, Nicole M Panhuyzen-Goedkoop17,18, Hein Heidbuchel19,20, Iacopo Olivotto21, Domenico Corrado22, Gianfranco Sinagra23, Sanjay Sharma3.   

Abstract

Myocardial diseases are associated with an increased risk of potentially fatal cardiac arrhythmias and sudden cardiac death/cardiac arrest during exercise, including hypertrophic cardiomyopathy, dilated cardiomyopathy, left ventricular non-compaction, arrhythmogenic cardiomyopathy, and myo-pericarditis. Practicing cardiologists and sport physicians are required to identify high-risk individuals harbouring these cardiac diseases in a timely fashion in the setting of preparticipation screening or medical consultation and provide appropriate advice regarding the participation in competitive sport activities and/or regular exercise programmes. Many asymptomatic (or mildly symptomatic) patients with cardiomyopathies aspire to participate in leisure-time and amateur sport activities to take advantage of the multiple benefits of a physically active lifestyle. In 2005, The European Society of Cardiology (ESC) published recommendations for participation in competitive sport in athletes with cardiomyopathies and myo-pericarditis. One decade on, these recommendations are partly obsolete given the evolving knowledge of the diagnosis, management and treatment of cardiomyopathies and myo-pericarditis. The present document, therefore, aims to offer a comprehensive overview of the most updated recommendations for practicing cardiologists and sport physicians managing athletes with cardiomyopathies and myo-pericarditis and provides pragmatic advice for safe participation in competitive sport at professional and amateur level, as well as in a variety of recreational physical activities.

Entities:  

Year:  2019        PMID: 30561613     DOI: 10.1093/eurheartj/ehy730

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  69 in total

Review 1.  Second Hits in Dilated Cardiomyopathy.

Authors:  Peter Marstrand; Kermshlise Picard; Neal K Lakdawala
Journal:  Curr Cardiol Rep       Date:  2020-01-24       Impact factor: 2.931

Review 2.  The effects of endurance exercise on the heart: panacea or poison?

Authors:  Gemma Parry-Williams; Sanjay Sharma
Journal:  Nat Rev Cardiol       Date:  2020-03-09       Impact factor: 32.419

3.  COVID-19 and cardiac considerations in the community.

Authors:  Christine A'Court; Mayooran Shanmuganathan; Juan Carlos Leoni-Moreno
Journal:  Br J Gen Pract       Date:  2020-10-29       Impact factor: 5.386

Review 4.  Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment.

Authors:  George Makavos; Chris Κairis; Maria-Eirini Tselegkidi; Theodoros Karamitsos; Angelos G Rigopoulos; Michel Noutsias; Ignatios Ikonomidis
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

Review 5.  Current challenges in sudden cardiac death prevention.

Authors:  Domenico Corrado; Alessandro Zorzi; Emilio Vanoli; Edoardo Gronda
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

Review 6.  Role of Exercise as a Modulating Factor in Arrhythmogenic Cardiomyopathy.

Authors:  Alessandro Zorzi; Alberto Cipriani; Riccardo Bariani; Kalliopi Pilichou; Domenico Corrado; Barbara Bauce
Journal:  Curr Cardiol Rep       Date:  2021-05-07       Impact factor: 2.931

7.  Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.

Authors:  Carlo Fumagalli; Niccolò Maurizi; Sharlene M Day; Euan A Ashley; Michelle Michels; Steven D Colan; Daniel Jacoby; Niccolò Marchionni; Justin Vincent-Tompkins; Carolyn Y Ho; Iacopo Olivotto
Journal:  JAMA Cardiol       Date:  2020-01-01       Impact factor: 14.676

8.  Pre-participation Cardiovascular Screening in Young Competitive Athletes.

Authors:  Bradley J Petek; Aaron L Baggish
Journal:  Curr Emerg Hosp Med Rep       Date:  2020-05-21

Review 9.  Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art Review.

Authors:  Nisha A Gilotra; Jan M Griffin; Noelle Pavlovic; Brian A Houston; Jessica Chasler; Colleen Goetz; Jonathan Chrispin; Michelle Sharp; Edward K Kasper; Edward S Chen; Ron Blankstein; Leslie T Cooper; Emer Joyce; Farooq H Sheikh
Journal:  J Card Fail       Date:  2021-07-11       Impact factor: 5.712

Review 10.  Hypertrophic Cardiomyopathy: Updates Through the Lens of Sports Cardiology.

Authors:  Bradley S Lander; Dermot M Phelan; Matthew W Martinez; Elizabeth H Dineen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.